July 2024 | AIChE

You are here

July 2024

Executive Committee elected for 2024-2025

Meet your officers and directors elected for the period 2024-2025. We did not have a candidate for Vice Chair, so this position will be vacant this coming year.

Brochure - Cuso de Aplicación de la RCD 203 -2020 OS/CD

Cuso de aplicación de la RCD 203 -2020 OS/CD para la implementación de un sistema de gestión de seguridad de procesos

Mathew Sudeesh

Accomplished Digital Transformation Leader | Strategic IT & OT Expert



With over 20 years of combined IT and OT experience, I specialize in driving digital transformation initiatives that strategically align technology solutions with business objectives. Currently leading Digital Transformation at Covestro, I have successfully engineered and implemented programs to digitalize operations, resulting in significant efficiency gains. I have architected a comprehensive data platform integrating energy, emissions, reliability, and safety data, thereby enhancing...Read more

Katelyn Kelsey Dubois

Katelyn has evaluated, developed, and implemented solutions across several technology domains, including ruggedized hardware, wearable devices, mobile worker connectivity, advanced process control, and wireless network infrastructure. Katelyn serves as Dow’s program manager for interactions with MxD, the digital advanced manufacturing institute where she also led efforts to develop and deploy a process industry test bed for piloting digital manufacturing and connected worker capabilities.  Katelyn joined Dow in 2017 within the Information Research group of Dow’s global Core R&D...Read more

Ryan Crisman



Ryan Crisman is the co-founder and Chief Technical Officer at Umoja Biopharma

Before starting Umoja in 2019, Ryan served as the Executive Director for the Gates Biomanufacturing Facility, where he was responsible for building out and staffing a protein and cell therapy CDMO. He was instrumental in growing the Gates facility’s cGMP capabilities, enabling the delivery of multiple first-in-human therapeutic products to patients. Prior to his work with Gates, Ryan led the CMC program for Juno Therapeutics’ CD19 CAR T-cell program BREYANZI and was the Head of Late-Stage...Read more

Yuta Lee



Yuta is the founder and CEO of Accelerated Bio, a regenerative medicine company based in Philadelphia commercializing the human Trophoblast Stem Cell (hTSC). hTSCs are the earliest pre-implantation, pre-placental cells that can be sourced ethically from an ectopic pregnancy. These naïve cells can scale to 85 population doublings with natural immune privilege, making them the most ideal starting cell source for allogeneic cell & gene therapies. The hTSC platform has been awarded 53 patents, providing freedom-to-operate for partners looking for a clear pathway to...Read more

Eugene Beh

Eugene Beh is the CEO of Quino Energy. Prior to co-founding Quino in 2021, Eugene was a Member of Research Staff at Xerox PARC, where he invented and commercialized a redox flow desalination technology platform, leading him to become PARC’s Most Prolific Inventor in 2020 and 2021.

Prior to PARC, Eugene was a postdoctoral fellow working on aqueous organic flow batteries with Prof. Mike Aziz and Prof. Roy Gordon at Harvard University. He earned a Ph.D. in Chemistry from Stanford, an A.M. in Chemistry from Harvard, and an A.B. in Chemistry and Physics summa cum laude from Harvard. He...Read more

Pages